News
Huvepharma has received FDA approval for Monovet® 90 (monensin Type A medicated article) to be fed with Pennchlor® (chlortetracycline Type A medication article).
Huvepharma® partners with Brazilian firm Champion Animal Health to become the sole distributor of JustiFLY® Feedthrough products in the United States.
Huvepharma®, Inc. is re-launching PoultrySulfa® (sulfamerazine, sulfamethazine and sulfaquinoxaline), bringing back the only FDA-approved triple-sulfa veterinary product available to the animal health market.
Peachtree City, GA (February 18th, 2022) – Huvepharma® is pleased to announce that Ed Bell, Tracy Harris Ⅲ, Doug Rupp and Dr. Doug Braun have joined the team since the beginning of the new year.
Peachtree City, GA (February 9th, 2022) – Huvepharma® announces FDA approval for Tilmovet® AC (tilmicosin phosphate)
PEACHTREE CITY, GA (June 8, 2020) — Global animal health company Huvepharma® has received FDA-approval for Vetmulin® 12.5% (tiamulin hydrogen fumarate).
Meet the Huvepharma Poultry Professional Services Team
Huvepharma Inc. Introduces New Vaccine to Combat Necrotic Enteritis
PEACHTREE CITY, GA (June 24, 2020) — Huvepharma® has received FDA-approval for CycleGuard® 500 (melengestrol acetate).
PEACHTREE CITY, GA (June 24, 2020) —Huvepharma®, a global human and animal pharmaceutical company, has named Dr. David Smith as the new Veterinary Technical Service Manager for the U.S. Poultry Team. Dr. Smith has extensive career experience in Veterinary Technical Services for some of the largest animal health companies in the poultry industry. The company […]
PEACHTREE CITY, GA (May 11, 2020) — Huvepharma, a global human and animal pharmaceutical company, has named three new members to the U.S. Poultry Team: Drew Weir will lead the team as the Director for U.S. Poultry. Steven Clark, DVM, will serve as the Veterinary Technical Services Manager; and Joe Williams will serve as Strategic […]
PEACHTREE CITY, GA (May 19, 2020) — Global animal health company, Huvepharma®, has received FDA-approval for Optigrid® 45 (ractopamine hydrochloride).
RESPIVax™ 5 + PH-M, a convenient, single dose vaccine to protect cattle against viral and bacteria challenges associated with Bovine Respiratory Disease (BRD), is now available from Huvepharma.
The first FDA-approved generic monensin – available to U.S. beef, dairy, and goat producers as Monovet®90 (monensin Type A medicated article) from global animal health company Huvepharma® – has now also received FDA approval for combination use with other drug feed additive products in the manufacture of Type B and C medicated feeds.
October 1, 2018 (Peachtree City, GA) – Huvepharma®, a fast-growing global pharmaceutical company focused on developing, manufacturing, and marketing human and animal health products, announces the release of a conditional licensed vaccine for the prevention of pinkeye caused by Moraxella bovoculi in cattle.
August 28, 2018 (Peachtree City, GA) – Huvepharma, a fast-growing global pharmaceutical company focused on developing, manufacturing, and marketing human and animal health products, announces the acquisition of T-HEXX Animal Health, a division of Hydromer, Inc. The T-HEXX lines of products are based upon innovative hydrophilic polymer technologies for animal health, primarily in the dairy and equine markets.
